You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 14 No. 5, May 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Brain Scanning in Ischemic Cerebrovascular Disease

ALBERT L. RHOTON, JR., MD; GEORGE H. KLINKERFUSS, MD; DOUGLAS R. LILLY, MD; MICHAEL M. TER-POGOSSIAN, PhD

Arch Neurol. 1966;14(5):506-511.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A PREVIOUS report from this institution indicated that brain scanning with radioactive chlormerodrin mercury may have diagnostic usefulness in patients with ischemic cerebrovascular disease.1 In a small series it was found that patients with a completed stroke frequently had areas of abnormal uptake on scan and that transient ischemic episodes were associated with a normal scan. Ojemann et al2 reported similar findings with the position-emitting radioisotopes. Since our initial report many more scans have been added to those on which that report was based, permitting a more complete evaluation of results in ischemic cerebrovascular disease. Special emphasis will be placed on (1) clinical characteristics of patients with abnormal scans, (2) characteristics of abnormal scans associated with cerebral infarction, (3) results of scans done subsequent to the original positive scan, and (4) selection of optimal interval between administration of chlormerodrin Hg 197 and scanning for areas of cerebral infarction. . . . [Full Text PDF of this Article]


Author Affiliations

ROCHESTER, MINN

From the Division of Neurosurgery, Beaumont-May Institute of Neurology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis.


Footnotes

Submitted for publication Dec 1, 1965; accepted Jan 10, 1966.

Reprint requests to Section of Neurological Surgery, Mayo Clinic, Rochester, Minn 55902 (Dr. Rhoton).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.